Syndax Pharmaceuticals (SNDX) Net Cash Flow (QoQ) (2015 - 2026)
Syndax Pharmaceuticals (SNDX) Net Cash Flow (QoQ) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Syndax Pharmaceuticals | 1.87 Bn | 1.52 Bn | 53.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -122.42% |
| Dec 31, 2025 | 120.35% |
| Sep 30, 2025 | 118.02% |
| Jun 30, 2025 | -50,296.67% |
| Mar 31, 2025 | -100.43% |
| Dec 31, 2024 | -23.74% |
| Sep 30, 2024 | 399.63% |
| Jun 30, 2024 | 94.90% |
| Mar 31, 2024 | -190.01% |
| Dec 31, 2023 | 7,470.42% |
| Sep 30, 2023 | -106.84% |
| Jun 30, 2023 | 336.71% |
| Mar 31, 2023 | -665.26% |
| Dec 31, 2022 | 106.10% |
| Sep 30, 2022 | 28.70% |
| Jun 30, 2022 | -106.48% |
| Mar 31, 2022 | -122.05% |
| Dec 31, 2021 | 4,337.85% |
| Sep 30, 2021 | -7.20% |
| Jun 30, 2021 | 107.19% |